A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2001
10/23/2001	CA1341306C Yeast expression of urokinase-type plasminogen activator and mutants thereof
10/18/2001	WO2001077378A2 Diagnosis of diseases associated with dna adducts
10/18/2001	WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001	WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001	WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001	WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001	WO2001077181A2 Anti-rhesus d monoclonal antibodies
10/18/2001	WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077139A1 8ss-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
10/18/2001	WO2001077138A1 8β-SUBSTITUTED-11β-PENTYL- AND 11β-HEXYL-ESTRA-1,3,5(10)-TRIENE DERIVATIVES
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077097A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001077082A1 Naphthalene derivatives
10/18/2001	WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001	WO2001077076A1 Novel naphthalene derivatives
10/18/2001	WO2001076640A2 Chemically modified novel erythropoietin stimulating protein compositions and methods
10/18/2001	WO2001076639A2 Chemically-modified myelopoietin conjugates
10/18/2001	WO2001076593A2 Bile secretion promoting composition a 15-keto prostaglandin
10/18/2001	WO2001076573A2 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
10/18/2001	WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties
10/18/2001	WO2001076451A2 Diagnosis of diseases associated with metabolism
10/18/2001	WO2001024817A3 Pharmaceutical compositions of fibrinolytic agent
10/18/2001	WO2001023388A3 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
10/18/2001	WO2000069898A8 Molecular interactions in allergy cells
10/18/2001	WO2000043498A9 Human liver progenitors
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001	US20010031858 Coupling of 2-(2-acetylamino-3-(4-amidinophenyl) propionylamino)-2-cyclohexylacetic acid with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt or a salt thereof; anticoagulants
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031770 Pyridoxal analogues and methods of treatment
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031282 Dissolving solid in dimethyl ether under pressure; precipitation; separation
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma
10/18/2001	DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405793A1 Combination of organic compounds
10/18/2001	CA2405561A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
10/18/2001	CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001	CA2405181A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403012A1 Chemical compounds
10/18/2001	CA2402410A1 The high bone mass gene of 11q13.3
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001	EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
10/17/2001	EP1144651A1 Polypeptides derived from jnk3
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144613A1 Methods for making proteins containing free cysteine residues
10/17/2001	EP1144594A1 Transgenic circulating endothelial cells
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144441A2 Disintegrin homologs
10/17/2001	EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144390A2 Kinase inhibitors
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones
10/17/2001	EP1144373A2 Serine protease inhibitors
10/17/2001	EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001	EP1144000A1 New dialysis method
10/17/2001	EP1143992A2 Therapeutic compositions containing glutathione analogs
10/17/2001	EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
10/17/2001	EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation
10/17/2001	EP0873110A4 Improved hemostatic composition for treating gingival area
10/17/2001	EP0842185B1 Ara-c derivatives
10/17/2001	CN1318069A Factor VIIa inhibitors
10/17/2001	CN1318054A Novel compounds
10/17/2001	CN1073159C Human kunitz-type protease inhibitors and its related method
10/17/2001	CN1072948C Process for preparing Chinese medicine 'Buxueyimu' particles
10/17/2001	CN1072943C Medicine for nosohemia and its prepn. method
10/17/2001	CN1072931C Method of inhibiting cell-cell adhesion
10/16/2001	US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/16/2001	US6303625 Triazolopyridines for the treatment of thrombosis disorders
10/16/2001	US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimers, parkinsons, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis
10/16/2001	US6302837 Benzothiophene, benzofuran and indole compounds
10/16/2001	CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same
10/11/2001	WO2001075107A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis
10/11/2001	WO2001075074A1 Novel proteins
10/11/2001	WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	WO2001074902A2 Adenine binding g protein coupled receptors

1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 671